Non-Surgical Pain Clinic Products in Gilbert, AZ

CDC PLACES vs. JF: two files, not one brochure

Gilbert is a city of 250k–500k (267,918 Census). CDC PLACES (2023, crude) estimates 8% of adults in Gilbert have diagnosed diabetes — 4.0 points below the U.S. 12% figure. Adult arthritis here is 20.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.

Epidemiology is not a protocol

• Adult arthritis here is 20.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 7.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Arizona.
• Arizona is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• Orthopedic and wound-care buyers in Arizona are often different people inside the same health system. A single Hawk Medical account can still require two utilization policies so 361 tissue and CTPs are not interchanged.

Uninsured mix and Medicare CTPs in the same building

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Gilbert is 8% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic